Encore: Medical Technology and Innovation
July 23, 2019
Hosted by Jose Negron
Today, Tomorrow’s Technology (T3) has had many technology topics discussed on the show. In the last two weeks, we have introduced the audience to Numobag Kit a wound care product and Neuchroma lenses. Today, we will continue our discussion on Medical Technology and Innovations products. Our guest today is Ms. Sarah Cristina Castillo Benitez a registered nurse and key international consultant for the Numobag Kit. She will help discuss the application of the Numobag Kit to Case 95. How the treatment saved a 95-year-old lady’s leg because she took a chance on a new technology and treatment. We will also, review other key medical technologies that are impacting our lifestyle. Today, Tomorrow’s Technologies (T3) show, we will continue to explore the science, technology and innovations discovered in the medical community in the US and around the world. Joins us today as Ms. Sarah Castillo discusses Case 95 and other key medical technologies that are changing the world of medicine.
Today, Tomorrow’s Technologies
Tuesday at 9 AM Pacific Time on VoiceAmerica Variety Channel
Today, Tomorrow’s Technologies (T3) enables our scientists, engineers and innovators to establish a daily dialogue with a non-techy listener. This engagement will expand our understanding of how technology can impact our daily lives. The goal is to simplify, avoid the tech mystery and encourage the study or participation in these new disciplines. T3 benefits will answer the following questions:
a. What are the positive or negative impacts in the new technology?
b. When can these technologies impact our daily routine?
c. How can society benefit from these technologies?
T3 will cover a variety of engineering, scientific and future technologies. Topics include autonomous vehicles, disruptive products, cyber technologies, smart homes/devices, unmanned aerial vehicles, smart phone, now what?, space exploration/activities, electric technologies, energy/alternate energy, tech government vs commercial, technology in high schools, future robots, and the next inventions.
Mr. Jose Negron is CEO/President at AVANTI Technologies, Inc., an Annandale, Virginia, veteran-owned small business. He retired from the USAF in 2005 in the rank of Colonel after 29 years of service.
Mr. Negron has 40 years of government and commercial experiences working on major technology programs, analytical activities with budgetary consequences, and pioneered research for the Defense Advanced Research Projects Agency (DARPA). His program manager experiences were tested leading to major application and research successes, in 1994 he led the Sarajevo/Rwanda Humanitarian relief effort with Geneva AirOps, Switzerland, in 1999 organized the first interaction to structure how the USAF Air Expeditionary Force (AEF) was to deploy, in 2000 led the analytic/tech study for the Air War over Serbia, led the 2004 1st DARPA Grand Challenge Autonomous Vehicle event across the Mojave desert. Currently, he leads two medical revolutionary efforts: 1) Numobag for advanced wound care, and 2) NeuChroma vision glasses, and today, the visionary for the technical understanding and visualization of electronic warfare (radio frequency) and cyber digital formats with impacts on humanity.
Mr. Negron’s technical insights are often sought out to assist or lead the future planning of research efforts as the result of his past successes to plan, schedule, integrate, and execute one-of-a-kind programs or activities leaving a positive mark on our nation and globally.